HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kezuka, T. Articles by Streilein, J. W. Search for Related Content PubMed PubMed Citation Articles by Kezuka, T. Articles by Streilein, J. W.

In Vitro Generation of Regulatory CD8⁺ T Cells Similar to those Found in Mice with Anterior Chamber–Associated Immune Deviation

From the Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

PURPOSE. When injected intravenously into naïve mice, peritoneal exudate cells (PECs) incubated with ovalbumin (OVA) in the presence of transforming growth factor (TGF)-ß2 induce immune deviation similar to that evoked by injection of OVA into the anterior chamber of the eye. Intraocular antigen injection elicits two distinct populations of regulatory T cells that impair delayed hypersensitivity (DH) by two different mechanisms: a CD4⁺ T cell that suppresses the induction of DH (afferent) and a CD8⁺ T cell that inhibits DH expression. In an effort to understand the origin and mechanism of action of these regulatory cells, CD8⁺ T cells from OVA-specific T cell receptor (Tcr) transgenic mice (OT-1) were used.

METHODS. CD8⁺ T cells were harvested from Tcr transgenic OT-I mice whose Tcr recognize an OVA peptide in the context of the class I major histocompatibility complex molecule K^b. These cells were stimulated in vitro with OVA-pulsed PECs exposed (or not) to TGF-ß2, then analyzed for their capacity to proliferate, to secrete various cytokines, to lyse OVA-expressing target cells, and to regulate bystander T cells in vitro and in vivo.

RESULTS. When OVA-pulsed PECs were used in vitro as stimulators, responding OT-I T cells proliferated and preferentially secreted interferon (IFN)-, interleukin (IL)-2, and tumor necrosis factor (TNF)-, rather than IL-4 and IL-10. When the stimulator PECs were pretreated with TGF-ß2 and then pulsed with OVA, responding OT-I T cells proliferated even more swiftly, but they secreted significantly less IFN-, IL-2, and TNF-, and no IL-4 or IL-10. OT-I T cells, which constitutively display cytotoxicity toward OVA-expressing target cells, lost this activity when stimulated with OVA-pulsed, TGF-ß2–pretreated PECs. Moreover, OT-I T cells stimulated in this manner displayed the capacity to inhibit proliferation of OVA-primed T cells exposed to OVA in vitro and to suppress in vivo the expression of OVA-triggered DH.

CONCLUSIONS. OVA-pulsed PECs, pretreated with TGF-ß2, coerce naïve OVA-specific CD8⁺ T cells to become efferent regulators of DH similar to the regulatory T cells evoked by intraocular injection of OVA.

This article has been cited by other articles:

				R. E. Cone, S. Chattopadhyay, R. Sharafieh, Y. Lemire, J. O'Rourke, R. A. Flavell, and R. B. Clark T cell sensitivity to TGF-{beta} is required for the effector function but not the generation of splenic CD8+ regulatory T cells induced via the injection of antigen into the anterior chamber Int. Immunol., May 1, 2009; 21(5): 567 - 574. [Abstract] [Full Text] [PDF]

				J. A. Kapp, K. Honjo, L. M. Kapp, X. y. Xu, A. Cozier, and R. P. Bucy TCR transgenic CD8+ T cells activated in the presence of TGF{beta} express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection Int. Immunol., November 1, 2006; 18(11): 1549 - 1562. [Abstract] [Full Text] [PDF]

				S. Masli, B. Turpie, and J W. Streilein Thrombospondin orchestrates the tolerance-promoting properties of TGF{beta}-treated antigen-presenting cells Int. Immunol., May 1, 2006; 18(5): 689 - 699. [Abstract] [Full Text] [PDF]

				H. Keino, S. Masli, S. Sasaki, J. W. Streilein, and J. Stein-Streilein CD8+ T Regulatory Cells Use a Novel Genetic Program that Includes CD103 to Suppress Th1 Immunity in Eye-Derived Tolerance. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1533 - 1542. [Abstract] [Full Text] [PDF]

				T. Kezuka, M. Takeuchi, H. Keino, Y. Usui, A. Takeuchi, N. Yamakawa, and M. Usui Peritoneal Exudate Cells Treated with Calcitonin Gene-Related Peptide Suppress Murine Experimental Autoimmune Uveoretinitis via IL-10 J. Immunol., July 15, 2004; 173(2): 1454 - 1462. [Abstract] [Full Text] [PDF]

				J. Zhang-Hoover and J. Stein-Streilein Tolerogenic APC Generate CD8+ T Regulatory Cells That Modulate Pulmonary Interstitial Fibrosis J. Immunol., January 1, 2004; 172(1): 178 - 185. [Abstract] [Full Text] [PDF]

				J. W. Streilein Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation J. Leukoc. Biol., August 1, 2003; 74(2): 179 - 185. [Abstract] [Full Text] [PDF]

				K. C. McKenna, Y. Xu, and J. A. Kapp Injection of Soluble Antigen into the Anterior Chamber of the Eye Induces Expansion and Functional Unresponsiveness of Antigen-Specific CD8+ T Cells J. Immunol., November 15, 2002; 169(10): 5630 - 5637. [Abstract] [Full Text] [PDF]

				Y. Wang, I. Goldschneider, J. O’Rourke, and R. E. Cone Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation J. Leukoc. Biol., May 1, 2001; 69(5): 741 - 746. [Abstract] [Full Text]

				G. E. Plautz, S. Mukai, P. A. Cohen, and S. Shu Cross-Presentation of Tumor Antigens to Effector T Cells Is Sufficient to Mediate Effective Immunotherapy of Established Intracranial Tumors J. Immunol., October 1, 2000; 165(7): 3656 - 3662. [Abstract] [Full Text] [PDF]